Key Segmentation
By Product
-
Consumables
-
Instruments
-
Services
-
Software & Bioinformatics Solutions
-
Others
By Technology
-
Sequencing by Synthesis (SBS)
-
Ion Semiconductor Sequencing
-
Nanopore Sequencing
-
SMRT Sequencing
-
Others
By Application
-
Cancer Diagnostics
-
Rare Disease Diagnosis
-
Personalized Medicine
-
Drug Discovery & Development
-
Others
By End User
-
Academic & Research Institutes
-
Hospitals & Clinics
-
Pharmaceutical & Biotechnology Companies
-
Diagnostic Laboratories
-
Others
By Workflow
-
Sequencing
-
Sample Preparation
-
Library Preparation
-
Data Analysis & Interpretation
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Whole Exome Sequencing Market in 2025.
The Sequencing segment dominated the Whole Exome Sequencing Market in 2025.
The major growth factor driving the market is the rising demand for precision medicine, targeted diagnostics, provides comprehensive genetic insights at lower cost compared to whole genome sequencing.
The Whole Exome Sequencing Market was valued at USD 2.22 billion in 2025.
The Whole Exome Sequencing Market is expected to grow at a CAGR of 16.70% from 2026 to 2035.